This functional interaction in between the serotoninergic and central dopaminergic systems is shown in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic results of psilocybin [five]. Psilocybin that contains mushrooms: a quickly establishing biotechnology market from the psychiatry, biomedical and nutraceutical fields The lawful status of psilo... https://entheogenic-mushrooms55429.fare-blog.com/28104455/indicators-on-psychedelic-mushrooms-you-should-know